Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▼ −1.7% | ▼ −6.3% | ▼ −24.4% | ▼ −43.2% | ▼ −51.3% | ▼ −75.8% | ▼ −68.7% | ▼ −99.9% |
| Peer average | ▲ +1.1% | ▲ +2.4% | ▼ −12.9% | ▼ −15.0% | ▼ −21.8% | ▼ −55.4% | ▼ −48.1% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-23 | 2026-09-29 | $0.14 |
| 2026-06-24 | 2026-06-30 | $0.14 |
| 2026-03-25 | 2026-03-31 | $0.14 |
| 2025-12-24 | 2025-12-31 | $0.21 |
| 2025-09-24 | 2025-09-30 | $0.31 |
| 2025-06-25 | 2025-07-01 | $0.22 |
| 2025-03-26 | 2025-04-01 | $0.27 |
| 2024-12-23 | 2024-12-31 | $0.41 |
| 2024-09-25 | 2024-10-02 | $0.30 |
| 2024-06-26 | 2024-07-03 | $0.32 |
| 2024-03-20 | 2024-03-27 | $0.32 |
| 2023-12-20 | 2023-12-28 | $0.35 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind BIS.